Skip to main content
. Author manuscript; available in PMC: 2013 Oct 9.
Published in final edited form as: Biochim Biophys Acta. 2012 Feb 9;1823(4):889–899. doi: 10.1016/j.bbamcr.2012.01.017

Table 2.

hMSH3 downregulation pattern in hypoxia in human cell lines derived from various origins.

Cell line Origin p53 Status mRNA level, %a
Down-regulation pattern
Day 1 Day 3
HCT116+5 colorectal cancer wild type 77.2 33.3b * Rapid
HCT116+3+5 colorectal cancer wild type 80.9 41.5* Rapid
HEK293 embryonic kidney wild type ntc 32.6* Rapid
SW480 colorectal cancer mutant 76.9 68.8* Moderate
SW620 colorectal cancer mutant 73.8 75.3b* Moderate
colo320DM colorectal cancer mutant nt 73.8 Moderate
HeLa S3 cervix carcinoma mutant nt 79.4* Moderate
TGW neuroblastoma mutant nt 69.5* Moderate
GOTO neuroblastoma wild type 107.5 96.2 No
MCF-7 breast adenocarcinoma wild type 103.6 100.6 No
*

P<0.05

a

Percentage of the relative mRNA amount in hypoxia was determined by the following formula: Ct at hypoxia/Ct at normoxia×100.

b

The mRNA level was determined at day 2 in hypoxia.

c

nt: not tested.